Liberty Defense Successfully Completes Testing and Evaluation at Major US Courthouse and Affiliated Correctional Facilities
WILMINGTON, Mass., June 23, 2025 ( GLOBE NEWSWIRE ) -- Liberty Defense Holdings Ltd. ( "Liberty" or the "Company" ) ( TSXV: SCAN, OTCQB: LDDFF, FSE: E30 ) , a leading technology provider of AI-based next generation detection solutions for concealed weapons and threats, is pleased to announce ...
Liberty Defense Successfully Completes Testing and Evaluation at Major US Courthouse and Affiliated Correctional Facilities - Liberty Defense Holdings ( OTC:LDDFF )
WILMINGTON, Mass., June 23, 2025 ( GLOBE NEWSWIRE ) -- Liberty Defense Holdings Ltd. ( "Liberty" or the "Company" ) SCANLDDFF FSE: E30 ) ) , a leading technology provider of AI-based next generation detection solutions for concealed weapons and threats, is pleased to announce that its HEXWAVE ...
EQS-PVR: RENK Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: RENK Group AG RENK Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group.
Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer
NEEDHAM, Mass., June 23, 2025 ( GLOBE NEWSWIRE ) -- Candel Therapeutics, Inc. ( Candel or the Company ) ( Nasdaq: CADL ) , a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the appointment of ...
NKGen Biotech Announces International and U.S. Expansion of Phase 1/2a Troculeucel Alzheimer's Trial with Activation of Clinical Sites in Canada and Florida
SANTA ANA, Calif., June 23, 2025 ( GLOBE NEWSWIRE ) -- NKGen Biotech, Inc. ( OTC: NKGN ) ( "NKGen" or the "Company" ) , a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer ( "NK" ) cell therapeutics, today ...
Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer - Candel Therapeutics ( NASDAQ:CADL )
NEEDHAM, Mass., June 23, 2025 ( GLOBE NEWSWIRE ) -- Candel Therapeutics, Inc. ( Candel or the Company ) CADL, a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the appointment of Charles Schoch as ...
NKGen Biotech Announces International and U.S. Expansion of Phase 1/2a Troculeucel Alzheimer's Trial with Activation of Clinical Sites in Canada and Florida
SANTA ANA, Calif., June 23, 2025 ( GLOBE NEWSWIRE ) -- NKGen Biotech, Inc. ( OTC: NKGN ) ( "NKGen" or the "Company" ) , a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer ( "NK" ) cell therapeutics, today ...
